Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region

Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially thos...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dermatology 2021-11, Vol.48 (11), p.1665-1674
Hauptverfasser: Tada, Yayoi, Jo, Seong Jin, Huang, Yu‐Huei, Wahking, Bryan, Lee, Bong Young, Gowindah, Regina, Fernández‐Peñas, Pablo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1674
container_issue 11
container_start_page 1665
container_title Journal of dermatology
container_volume 48
creator Tada, Yayoi
Jo, Seong Jin
Huang, Yu‐Huei
Wahking, Bryan
Lee, Bong Young
Gowindah, Regina
Fernández‐Peñas, Pablo
description Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.
doi_str_mv 10.1111/1346-8138.16072
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9290722</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2555968903</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</originalsourceid><addsrcrecordid>eNqFkb1OwzAUhS0EglKYWSOxsAT8FydekBD_CAkGmC3XuS1GiV3spIiNR-AZeRKcFiHBgpdrXX_n6F4fhPYIPiTpHBHGRV4RVh0SgUu6hkY_nXU0wqwqcspxuYW2Y3zGmMqC4E20xTgjFZflCN0_OuMXEKybZd0TZL1rocscQB0z3frUnUcfrI42ZnPdWXBdzKxbsifR6s_3j3tt7NSaLMDMereDNqa6ibD7Xcfo8eL84fQqv727vD49uc0NFxXNaS14STkrJlrWHJisiaC0pFMzVE0FCGKETldGuBE1VEbLxGFNjJzgko3R8cp33k9aqE0aLOhGzYNtdXhTXlv1-8XZJzXzCyWpTD9Fk8HBt0HwLz3ETrU2Gmga7cD3UdGiKKSoJGYJ3f-DPvs-uLReoiSuJCNyMDxaUSb4GANMf4YhWA1pqSEbNWSjlmklRbFSvNoG3v7D1c3Z-Ur3BU7blag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2590893192</pqid></control><display><type>article</type><title>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</title><source>Wiley Journals</source><creator>Tada, Yayoi ; Jo, Seong Jin ; Huang, Yu‐Huei ; Wahking, Bryan ; Lee, Bong Young ; Gowindah, Regina ; Fernández‐Peñas, Pablo</creator><creatorcontrib>Tada, Yayoi ; Jo, Seong Jin ; Huang, Yu‐Huei ; Wahking, Bryan ; Lee, Bong Young ; Gowindah, Regina ; Fernández‐Peñas, Pablo</creatorcontrib><description>Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.16072</identifier><identifier>PMID: 34318497</identifier><language>eng</language><publisher>Tokyo: Wiley Subscription Services, Inc</publisher><subject>Biological products ; biologics ; flare‐ups ; Health behavior ; Health psychology ; Original ; Patient compliance ; Patients ; Psoriasis ; psoriasis treatment ; quality of life ; Skin</subject><ispartof>Journal of dermatology, 2021-11, Vol.48 (11), p.1665-1674</ispartof><rights>2021 The Authors. The published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Dermatological Association</rights><rights>2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</citedby><cites>FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</cites><orcidid>0000-0003-4882-1564 ; 0000-0001-6016-8209</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.16072$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.16072$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Tada, Yayoi</creatorcontrib><creatorcontrib>Jo, Seong Jin</creatorcontrib><creatorcontrib>Huang, Yu‐Huei</creatorcontrib><creatorcontrib>Wahking, Bryan</creatorcontrib><creatorcontrib>Lee, Bong Young</creatorcontrib><creatorcontrib>Gowindah, Regina</creatorcontrib><creatorcontrib>Fernández‐Peñas, Pablo</creatorcontrib><title>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</title><title>Journal of dermatology</title><description>Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.</description><subject>Biological products</subject><subject>biologics</subject><subject>flare‐ups</subject><subject>Health behavior</subject><subject>Health psychology</subject><subject>Original</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Psoriasis</subject><subject>psoriasis treatment</subject><subject>quality of life</subject><subject>Skin</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqFkb1OwzAUhS0EglKYWSOxsAT8FydekBD_CAkGmC3XuS1GiV3spIiNR-AZeRKcFiHBgpdrXX_n6F4fhPYIPiTpHBHGRV4RVh0SgUu6hkY_nXU0wqwqcspxuYW2Y3zGmMqC4E20xTgjFZflCN0_OuMXEKybZd0TZL1rocscQB0z3frUnUcfrI42ZnPdWXBdzKxbsifR6s_3j3tt7NSaLMDMereDNqa6ibD7Xcfo8eL84fQqv727vD49uc0NFxXNaS14STkrJlrWHJisiaC0pFMzVE0FCGKETldGuBE1VEbLxGFNjJzgko3R8cp33k9aqE0aLOhGzYNtdXhTXlv1-8XZJzXzCyWpTD9Fk8HBt0HwLz3ETrU2Gmga7cD3UdGiKKSoJGYJ3f-DPvs-uLReoiSuJCNyMDxaUSb4GANMf4YhWA1pqSEbNWSjlmklRbFSvNoG3v7D1c3Z-Ur3BU7blag</recordid><startdate>202111</startdate><enddate>202111</enddate><creator>Tada, Yayoi</creator><creator>Jo, Seong Jin</creator><creator>Huang, Yu‐Huei</creator><creator>Wahking, Bryan</creator><creator>Lee, Bong Young</creator><creator>Gowindah, Regina</creator><creator>Fernández‐Peñas, Pablo</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4882-1564</orcidid><orcidid>https://orcid.org/0000-0001-6016-8209</orcidid></search><sort><creationdate>202111</creationdate><title>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</title><author>Tada, Yayoi ; Jo, Seong Jin ; Huang, Yu‐Huei ; Wahking, Bryan ; Lee, Bong Young ; Gowindah, Regina ; Fernández‐Peñas, Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4682-2d6472435ba9d4e39d162272fc1622a26e61c6a22a314c6de8ca94e30a1c9b073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Biological products</topic><topic>biologics</topic><topic>flare‐ups</topic><topic>Health behavior</topic><topic>Health psychology</topic><topic>Original</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Psoriasis</topic><topic>psoriasis treatment</topic><topic>quality of life</topic><topic>Skin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tada, Yayoi</creatorcontrib><creatorcontrib>Jo, Seong Jin</creatorcontrib><creatorcontrib>Huang, Yu‐Huei</creatorcontrib><creatorcontrib>Wahking, Bryan</creatorcontrib><creatorcontrib>Lee, Bong Young</creatorcontrib><creatorcontrib>Gowindah, Regina</creatorcontrib><creatorcontrib>Fernández‐Peñas, Pablo</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tada, Yayoi</au><au>Jo, Seong Jin</au><au>Huang, Yu‐Huei</au><au>Wahking, Bryan</au><au>Lee, Bong Young</au><au>Gowindah, Regina</au><au>Fernández‐Peñas, Pablo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region</atitle><jtitle>Journal of dermatology</jtitle><date>2021-11</date><risdate>2021</risdate><volume>48</volume><issue>11</issue><spage>1665</spage><epage>1674</epage><pages>1665-1674</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>Studies on the psychosocial and emotional burden of psoriasis have been extensive; however, there is limited knowledge and awareness of patients’ attitude and behavior towards psoriasis treatment. To understand psoriasis patients’ attitude and behavior towards treatment of psoriasis, especially those treated with biologics, a multi‐stage study qualitative and quantitative methodology was conducted among psoriasis patients. An online survey was conducted with 45 moderate‐to‐severe psoriasis patients each in Australia, Japan, South Korea, and Taiwan for 20 min. This was followed by qualitative in‐depth interviews conducted among psoriasis patients in Australia (n = 3) and Japan (n = 2) for 60 min. All of the findings were workshopped with key opinion leaders and patient advisory groups to identify potential solutions addressing patients’ unmet needs. Five common insights were identified across the region, highlighting patients’ attitude and behavior towards psoriasis treatment, especially for those treated with biologics. These insights comprised the following: (i) one of the key factors driving patients’ treatment choice included their ability to enjoy clear skin for longer period (68%); (ii) bio‐maintenance patients had a higher expectation (4.9 months) of how long their skin could stay clear, compared to their pre‐biologics initiation days (2.9 months); (iii) once a good response is achieved, bio‐maintenance patients were more concerned about symptoms returning (44%) than development of side‐effects (19%); (iv) bio‐maintenance patients felt psychologically and physically affected during flare‐ups despite being on more efficacious treatment; and (v) bio‐maintenance patients still felt they were at risk of flare‐ups (4.5/7), almost similar risk perception as non‐biologics patients (4.9/7). Findings from this study showed that psoriasis patients look for treatment with the least risk of flare‐ups so that they were able to enjoy clear skin for a long time.</abstract><cop>Tokyo</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34318497</pmid><doi>10.1111/1346-8138.16072</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-4882-1564</orcidid><orcidid>https://orcid.org/0000-0001-6016-8209</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2021-11, Vol.48 (11), p.1665-1674
issn 0385-2407
1346-8138
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9290722
source Wiley Journals
subjects Biological products
biologics
flare‐ups
Health behavior
Health psychology
Original
Patient compliance
Patients
Psoriasis
psoriasis treatment
quality of life
Skin
title Uncovering the unmet needs among psoriasis patients in the Asia‐Pacific region
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T02%3A06%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uncovering%20the%20unmet%20needs%20among%20psoriasis%20patients%20in%20the%20Asia%E2%80%90Pacific%20region&rft.jtitle=Journal%20of%20dermatology&rft.au=Tada,%20Yayoi&rft.date=2021-11&rft.volume=48&rft.issue=11&rft.spage=1665&rft.epage=1674&rft.pages=1665-1674&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.16072&rft_dat=%3Cproquest_pubme%3E2555968903%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2590893192&rft_id=info:pmid/34318497&rfr_iscdi=true